Velsipity Side Effects

Generic name: etrasimod

Medically reviewed by Drugs.com. Last updated on Aug 22, 2023.

Note: This document contains side effect information about etrasimod. Some dosage forms listed on this page may not apply to the brand name Velsipity.

Applies to etrasimod: oral tablet.

Serious side effects of Velsipity

Along with its needed effects, etrasimod (the active ingredient contained in Velsipity) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking etrasimod:

Less common

• Bladder pain
• bloody or cloudy urine
• blurred vision
• burning or stinging of the skin
• dark urine
• difficult, burning, or painful urination
• dizziness
• frequent urge to urinate
• headache
• large amount of cholesterol in the blood
• light-colored stools
• lower back or side pain
• nausea and vomiting
• nervousness
• painful blisters on the trunk of body
• painful cold sores or blisters on the lips, nose, eyes, or genitals
• pounding in the ears
• slow or fast heartbeat
• stomach pain or bloating
• yellow eyes or skin

Incidence not known

• Back pain
• changes in vision
• chest pain, discomfort, or tightness
• confusion
• drowsiness
• fever
• general feeling of illness
• mild burning, stinging, or tingling of the skin, or a feeling of heat, redness, or swelling of the skin
• persistent non-healing sore
• pink growth
• reddish patch or irritated area
• seizures
• shiny bump
• stiff neck or back
• trouble breathing
• unusual tiredness or weakness
• white, yellow or waxy scar-like area

For Healthcare Professionals

Applies to etrasimod: oral tablet.

Immunologic

Common (1% to 10%): Decrease of lymphocyte counts to less than 0.2 x 10(9)/L^[Ref]

Musculoskeletal

Common (1% to 10%): Arthralgia^[Ref]

Ocular

Common (1% to 10%): Decrease in visual acuity^[Ref]

Metabolic

Common (1% to 10%): Hypercholesterolemia^[Ref]

Genitourinary

Common (1% to 10%): Urinary tract infections^[Ref]

Hepatic

Common (1% to 10%): Elevated liver tests^[Ref]

Other

Very common (10% or more): Overall infections (25%)

Common (1% to 10%): Herpes viral infection^[Ref]

Nervous system

Common (1% to 10%): Dizziness^[Ref]

Cardiovascular

Common (1% to 10%): Hypertension, bradycardia

Uncommon (0.1% to 1%): First or second degree Mobitz type I AV blocks^[Ref]

Gastrointestinal

Common (1% to 10%): Nausea^[Ref]

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.

Medical Disclaimer